United States and Canada — Total Revenue
Illumina United States and Canada — Total Revenue increased by 6.3% to $590.00M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing adoption of genomic tools or expanded market share in the North American region, while a decrease may signal regional economic headwinds, increased competition, or a slowdown in research and clinical sequencing activity.
Detailed definition
This metric represents the total net revenue generated from the sale of sequencing instruments, consumables, and related...
Peer comparison
Peers in the life sciences and diagnostics sector typically report regional revenue splits to highlight geographic concentration and exposure to specific healthcare regulatory environments.
ilmn_segment_united_states_and_canada_total_revenueHistorical Data
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $555.00M | $590.00M |
| QoQ Change | — | +6.3% |
| YoY Change | — | +6.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Illumina's united states and canada — total revenue?
- Illumina (ILMN) reported united states and canada — total revenue of $590.00M in Q1 2026.
- What does united states and canada — total revenue mean?
- The total revenue earned from customers located in the United States and Canada.